# Ensysce Biosciences, Inc.: Form DEF 14A, filed Oct 18, 2024

- Company: [Ensysce Biosciences, Inc.](/companies/ensc.md) (CIK 1716947)
- Form: DEF 14A
- Filed: 2024-10-18
- Accepted by EDGAR: Oct 17, 2024, 21:34 ET
- Period: 2024-10-17
- Accession: 0001493152-24-041470
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1716947/000149315224041470/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716947/000149315224041470/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716947/000149315224041470/formdef14a.htm

Filed Oct 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-041470. Last ingested by Listed: Nov 4, 2026, 12:47 ET. No prices; not investment advice.